| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |